Search alternatives:
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
reference price » reference service (Expand search), reference process (Expand search), reference point (Expand search)
price decrease » price increase (Expand search), juice decreases (Expand search), price increases (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease akt » decrease at (Expand search), decrease and (Expand search), decrease with (Expand search)
akt decrease » and decrease (Expand search), not decrease (Expand search), any decrease (Expand search)
decrease processes » disease processes (Expand search), decay processes (Expand search), increase process (Expand search)
decrease decrease » decrease release (Expand search), disease decreases (Expand search), decreases disease (Expand search)
reference price » reference service (Expand search), reference process (Expand search), reference point (Expand search)
price decrease » price increase (Expand search), juice decreases (Expand search), price increases (Expand search)
decrease after » increase after (Expand search), disease after (Expand search)
decrease akt » decrease at (Expand search), decrease and (Expand search), decrease with (Expand search)
akt decrease » and decrease (Expand search), not decrease (Expand search), any decrease (Expand search)
1
2
3
4
“... de sinalização EGFR/ PI3K/ AKT/ mTOR que está relacionada a processos biológicos de sobrevivência e crescimento...”
Access document
Access document
Bachelor thesis
5
6
7
8
9
10
11
12
“... in medicines reference prices (AFP-II) and b) 2011 implementation of free medicines program for hypertension...”
Access document
Access document
Article
13
“... in medicines reference prices (AFP-II) and b) 2011 implementation of free medicines program for hypertension...”
Access document
Access document
Article
14
15
“... molecule prices, suggesting significant cost-savings, and that patients’ copayments decrease despite the...”
Access document
Access document
Article
16
17
18
19
20